Hui Liu, Professor
Eastern Hepatobiliary Surgery Hospital · Sun yat-sen universtiy cancer center · Sun Yat-Sen University Cancer Center
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Hui Liu, Professor as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 11:19 UTC. Open this list on ClinicalTrials.gov
- N/ANCT07707661 · Application of Super-Resolution Ultrasound (SRUS) in Liver TumorEastern Hepatobiliary Surgery Hospital · not yet recruiting · Hepatocellular Carcinoma (HCC), Intrahepatic Cholangiocellular Carcinoma, Hepatic Hemangioma · study chair
- Ph3NCT07052669 · Hypofractionated Versus Conventional Chemoradiotherapy Followed by Consolidative Immunotherapy in Locally Advanced NSCLCSun Yat-sen University · recruiting · Locally Advanced Non-Small Cell Lung Cancer · principal investigator
- Ph2NCT06912074 · Hypofractionated vs. Conventional Chemoradiotherapy After Induction Chemo-immunotherapy for Unresectable Esophageal Squamous Cell CarcinomaSun Yat-sen University · recruiting · Esophageal Squamous Cell Carcinoma (ESCC) · principal investigator
- Ph3NCT06734702 · Neoadjuvant Immunotherapy Plus Chemotherapy Followed by Concurrent Chemoradiotherapy and Consolidative Immunotherapy for Locally Advanced Non-small Cell Lung CancerSun Yat-sen University · recruiting · Neoadjuvant Therapy, Concurrent Chemoradiotherapy, Immunotherapy · principal investigator
- Ph2NCT06719700 · Concurrent Chemoradiotherapy Combined With Toripalimab and Surufatinib in the Treatment of Limited-Stage Small Cell Lung CancerSun Yat-sen University · recruiting · Toripalimab, Surufatinib, Chemoradiotherapy · principal investigator
- Ph2NCT06542159 · Elimination of PTV Margins Based on Online Adaptive Stereotactic Radiotherapy for Early-stage Non-small Cell Lung Cancer or Pulmonary OligometastasesSun Yat-sen University · recruiting · Adaptive Radiotherapy, Stereotactic Body Radiotherapy, Non-small Cell Lung Cancer · principal investigator
- Ph2NCT06281886 · Induction Immuno-chemotherapy and Concurrent Chemoradiotherapy With or Without Apatinib in Unresectable, Locally Advanced Esophageal Squamous Cell CarcinomaSun Yat-sen University · completed · Esophageal Squamous Cell Carcinoma, Efficacy, Toxicity · principal investigator
- Ph2NCT06139419 · The Impact of Thymosin α-1 on the Efficacy of Concurrent Chemoradiotherapy Followed by Immunotherpay Consolidation for Locally Advanced NSCLCSun Yat-sen University · completed · Non-small Cell Lung Cancer · principal investigator
- Ph1NCT06020885 · Fraction Dose Escalation of Split-course Hypofractionated Concurrent Chemoradiotherapy Following Induction Chemo-immunotherapy in Unresectable Locally Advanced Esophageal Squamous Carcinoma: a Phase I Study.Sun Yat-sen University · active not recruiting · Esophageal Squamous Cell Carcinoma · principal investigator
- Ph2NCT05481775 · Evaluating Efficacy and Safety of Anlotinib Combined With Concurrent Chemoradiotherapy Followed by Consolidation Immunotherapy for Locally Advanced Non-small Cell Lung CancerSun Yat-sen University · withdrawn · Locally Advanced Non-small Cell Lung Cancer, Efficacy and Safety · principal investigator
- Ph3NCT04980716 · Early Specialized Cardiovascular Intervention Based on Impedance Cardiography in Locally Advanced Non-small Cell Lung Cancer PatientsSun Yat-sen University · recruiting · Non-small Cell Lung Cancer, Cardiovascular Complication · principal investigator
- Ph1NCT04951063 · Fraction Dose Escalation of Hypo-fractionated Radiotherapy in LANSCLCSun Yat-sen University · completed · Locally Advanced Lung Carcinoma · principal investigator
- Ph2NCT04844385 · Toripalimab Plus Neoadjuvant Chemotherapy Combined With Chemoradiotherapy for Locally Advanced Unresectable Esophageal Squamous Cell CarcinomaSun Yat-sen University · unknown · Esophageal Squamous Cell Carcinoma · principal investigator
- Ph2NCT03904563 · Bevacizumab After Chemoradiotherapy For Locally Advanced Lung AdenocarcinomaSun Yat-sen University · completed · Lung Adenocarcinoma · principal investigator
- Ph2NCT03905317 · Bevacizumab and Radiotherapy for Oligometastasis of Lung Adenocarcinoma With Negative Driver GeneSun Yat-sen University · unknown · Lung Adenocarcinoma · principal investigator
- Ph2NCT03673657 · Study of Early Nutritional Intervention During Concurrent Chemoradiotherapy for Local Advanced Non-small Cell Lung CancerSun Yat-sen University · completed · Local Advanced Non-small Cell Lung Cancer · principal investigator
- Ph2NCT03663764 · Hypofractionated Chemoradiotherapy and Thymosin α1 in Unresectable or Recurrent Thymic Epithelial TumorSun Yat-sen University · unknown · Thymoma and Thymic Carcinoma · principal investigator
- Ph2NCT03661567 · Methylprednisolone After Split-course Chemoradiotherapy For Bulky Local Advanced None-small Cell Lung CancerSun Yat-sen University · terminated · Non-small Cell Lung Cancer · principal investigator
- Ph2NCT03006575 · Study of Split-course Chemoradiotherapy For Postoperative Locoregional Recurrence Of Non-small Cell Lung CancerSun Yat-sen University · unknown · Non-small Cell Lung Cancer · principal investigator
- Ph2NCT02606916 · Radiotherapy Combined With S-1/DDP for Elderly Esophageal Squamous Cell Cancer.Sun Yat-sen University · completed · Esophageal Squamous Cell Carcinoma · principal investigator
- Ph2NCT02577341 · Nimotuzumab Combined With Chemoradiotherapy for Unresectable Locally Advanced Squamous Cell Lung CancerSun Yat-sen University · completed · Non-small-cell Lung Cancer · principal investigator
- Ph2NCT02556593 · IMRT Combined With Erlotinib for EGFR Wild Type Non-small Cell Lung Cancer With 4-10 Brain MetastasesSun Yat-sen University · terminated · Non-Small Cell Lung Carcinoma · principal investigator
- Ph2NCT02337712 · Once-daily Simultaneous Modulated Accelerated Thoracic Radiotherapy in Limited Small-cell Lung CancerSun Yat-sen University · unknown · Small Cell Lung Cancer · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 11:19 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name in non-small cell lung cancer.